Author Question: If a pharmaceutical company wished to design a drug to maintain low blood sugar (Read 578 times)

TI

  • Sr. Member
  • ****
  • Posts: 434
If a pharmaceutical company wished to design a drug to maintain low blood sugar levels, one approach might be to design a compound
A) that mimics epinephrine and can bind to the epinephrine receptor.
B) that stimulates cAMP production in liver cells.
C) to stimulate G protein activity in liver cells.
D) that increases phosphodiesterase activity.
E) that does any of the above.



coco

  • Hero Member
  • *****
  • Posts: 739
In class, we found it was D. Good luck with the rest.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

TI

  • Sr. Member
  • ****
  • Posts: 434

 

Did you know?

Today, nearly 8 out of 10 pregnant women living with HIV (about 1.1 million), receive antiretrovirals.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

Bacteria have flourished on the earth for over three billion years. They were the first life forms on the planet.

Did you know?

There are actually 60 minerals, 16 vitamins, 12 essential amino acids, and three essential fatty acids that your body needs every day.

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

For a complete list of videos, visit our video library